Clinically, it was defined as the inability of glucose uptake and utilization by insulin-dependent tissues and reduced insulin sensitivity, being the basis of type 2 diabetes mellitus (DM2) [1–3]. The gene discussed is INS; the disease is type 2 diabetes mellitus.